146 related articles for article (PubMed ID: 35412073)
1. The grapefruit polyphenol naringenin inhibits multiple cardiac ion channels.
Sanson C; Boukaiba R; Houtmann S; Maizières MA; Fouconnier S; Partiseti M; Bohme GA
Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):735-740. PubMed ID: 35412073
[TBL] [Abstract][Full Text] [Related]
2. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition.
Lin C; Ke X; Ranade V; Somberg J
Cardiology; 2008; 110(3):145-52. PubMed ID: 18057881
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation.
Scholz EP; Zitron E; Kiesecker C; Lück S; Thomas D; Kathöfer S; Kreye VA; Katus HA; Kiehn J; Schoels W; Karle CA
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):516-25. PubMed ID: 16007460
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
Crumb WJ; Vicente J; Johannesen L; Strauss DG
J Pharmacol Toxicol Methods; 2016; 81():251-62. PubMed ID: 27060526
[TBL] [Abstract][Full Text] [Related]
5. The atypic antipsychotic clozapine inhibits multiple cardiac ion channels.
Le Marois M; Sanson C; Maizières MA; Partiseti M; Bohme GA
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jan; 396(1):161-166. PubMed ID: 36308551
[TBL] [Abstract][Full Text] [Related]
6. QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids.
Zitron E; Scholz E; Owen RW; Lück S; Kiesecker C; Thomas D; Kathöfer S; Niroomand F; Kiehn J; Kreye VA; Katus HA; Schoels W; Karle CA
Circulation; 2005 Feb; 111(7):835-8. PubMed ID: 15710766
[TBL] [Abstract][Full Text] [Related]
7. Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.
Koenig X; Kovar M; Rubi L; Mike AK; Lukacs P; Gawali VS; Todt H; Hilber K; Sandtner W
Toxicol Appl Pharmacol; 2013 Dec; 273(2):259-68. PubMed ID: 23707769
[TBL] [Abstract][Full Text] [Related]
8. In vitro ion channel profile and ex vivo cardiac electrophysiology properties of the R(-) and S(+) enantiomers of hydroxychloroquine.
Ballet V; Bohme GA; Brohan E; Boukaiba R; Chambard JM; Angouillant-Boniface O; Carriot T; Chantoiseau C; Fouconnier S; Houtmann S; Prévost C; Schombert B; Schio L; Partiseti M
Eur J Pharmacol; 2022 Jan; 915():174670. PubMed ID: 34863995
[TBL] [Abstract][Full Text] [Related]
9. Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-à-go-go-Related Gene) Channel-Drug Binding Kinetics and Multichannel Pharmacology.
Li Z; Dutta S; Sheng J; Tran PN; Wu W; Chang K; Mdluli T; Strauss DG; Colatsky T
Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):e004628. PubMed ID: 28202629
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol inhibits multiple cardiac ion channels and shortens ventricular action potential duration in vitro.
Le Marois M; Ballet V; Sanson C; Maizières MA; Carriot T; Chantoiseau C; Partiseti M; Bohme GA
Eur J Pharmacol; 2020 Nov; 886():173542. PubMed ID: 32910945
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Profile of the Bradycardic Agent Ivabradine on Human Cardiac Ion Channels.
Haechl N; Ebner J; Hilber K; Todt H; Koenig X
Cell Physiol Biochem; 2019; 53(1):36-48. PubMed ID: 31169990
[TBL] [Abstract][Full Text] [Related]
13. Mesoridazine: an open-channel blocker of human ether-a-go-go-related gene K+ channel.
Su Z; Martin R; Cox BF; Gintant G
J Mol Cell Cardiol; 2004 Jan; 36(1):151-60. PubMed ID: 14734057
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
[TBL] [Abstract][Full Text] [Related]
15. Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels.
Kuryshev YA; Bruening-Wright A; Brown AM; Kirsch GE
J Cardiovasc Pharmacol; 2010 Oct; 56(4):420-30. PubMed ID: 20930594
[TBL] [Abstract][Full Text] [Related]
16. QT interval prolongation and cardiac risk assessment for novel drugs.
Picard S; Lacroix P
Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
[TBL] [Abstract][Full Text] [Related]
17. Blockade of HERG cardiac K+ current by antifungal drug miconazole.
Kikuchi K; Nagatomo T; Abe H; Kawakami K; Duff HJ; Makielski JC; January CT; Nakashima Y
Br J Pharmacol; 2005 Mar; 144(6):840-8. PubMed ID: 15778703
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the HERG channel by droperidol depends on channel gating and involves the S6 residue F656.
Luo T; Luo A; Liu M; Liu X
Anesth Analg; 2008 Apr; 106(4):1161-70, table of contents. PubMed ID: 18349188
[TBL] [Abstract][Full Text] [Related]
19. MICE models: superior to the HERG model in predicting Torsade de Pointes.
Kramer J; Obejero-Paz CA; Myatt G; Kuryshev YA; Bruening-Wright A; Verducci JS; Brown AM
Sci Rep; 2013; 3():2100. PubMed ID: 23812503
[TBL] [Abstract][Full Text] [Related]
20. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
